Identification of a disulfidptosis-related lncRNA signature for the prognostic and immune landscape prediction in head and neck squamous cell carcinoma
ConclusionThese findings demonstrate that the developed DRlncRNA signature holds promise as a reliable prognostic marker and predictor of immunotherapy response in HNSCC patients.
Source: Hormones and Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Head and Neck Cancer | HNSCC | Hormones | Immunotherapy | Skin Cancer | Squamous Cell Carcinoma | Training | Universities & Medical Training